News ArticleTata Consultancy Services Notifies Shareholders to Register or Update Email Addresses for Effective Communication
Notice published in major newspapers outlines steps for dematerialized and physical shareholders to update email details with the company or registrar by November 2026
Tata Consultancy Services Ltd has published a notice urging shareholders who have not updated their email addresses with the company or their depository participants to register or update them. This ensures timely and effective communication. The process differs for dematerialized and physical shareholders with specific instructions provided for each category.
Tata Consultancy Services Limited
General / Other
Tata Consultancy Services Limited has issued a notice requesting shareholders who have not updated their email addresses with the company or their depository participants to do so promptly to ensure timely communication.
The notice, published on November 3, 2026, in newspapers including Business Standard, Free Press Journal, and Navshakti, instructs shareholders holding shares in dematerialized form to contact their respective depository participants to enable electronic communication.
Shareholders holding shares in physical form must submit Form ISR-1 along with self-attested copies of their PAN card and a cancelled cheque leaf to the Registrar and Share Transfer Agent at C-101, 247 Park, L B S Marg, Vikhroli (West), Mumbai - 400083 or via email at [email protected].
These measures are aimed at updating shareholders' contact information to facilitate effective and timely shareholder communications in compliance with SEBI Listing Regulations.
Highlights
- Notice issued under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, 2015.
- Applicable to shareholders with unregistered or outdated email addresses.
- Different procedures for dematerialized and physical shareholders for updating email information.
- Form ISR-1 required for physical shareholders to update details.
- Registrar and Share Transfer Agent address: C-101, 247 Park, L B S Marg, Vikhroli (West), Mumbai - 400083.
- Emails can also be sent to [email protected] for physical shareholding updates.
Key Data Snapshot
What happened
- Tata Consultancy Services Limited issued a public notice for shareholders to register or update their email addresses.
- The notice aims to ensure timely and effective shareholder communication as per SEBI regulations.
- Published in Business Standard, Free Press Journal, and Navshakti on November 3, 2026.
Key details
- Dematerialized shareholders to contact their Depository Participants to enable electronic communication.
- Physical shareholders to submit Form ISR-1 along with PAN card and cancelled cheque leaf to the Registrar & Share Transfer Agent or by email.
- The Registrar's address and email are explicitly provided for shareholders' use.
Regulatory and governance context
- Notice issued pursuant to Regulation 30 read with Schedule III Part A Para A of SEBI Listing Regulations, 2015.
- Compliance with updated listing obligations for shareholder communication.
Highlights
- Notice issued under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, 2015.
- Applicable to shareholders with unregistered or outdated email addresses.
- Different procedures for dematerialized and physical shareholders for updating email information.
- Form ISR-1 required for physical shareholders to update details.
- Registrar and Share Transfer Agent address: C-101, 247 Park, L B S Marg, Vikhroli (West), Mumbai - 400083.
- Emails can also be sent to [email protected] for physical shareholding updates.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Biocon Limited Reports Q2 FY2027 Profit of Rs. 917 Million and Announces New CTO Appointment
Biocon Limited disclosed its unaudited standalone financial results for the quarter and half year ending September 30, 2026, with a quarterly profit of Rs. 917 million. The board also approved the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as CTO starting January 1, 2027.
Read Full Story
Biocon Reports Q2 FY27 Total Income of Rs 4,423 Crore With Biopharma Revenue Up 5% and $400 Million Pertuzumab Deal
Biocon Limited announced consolidated total income of Rs 4,423 crore for the second quarter of fiscal year 2027, with biopharma revenues increasing by 5% year-on-year to Rs 3,583 crore. The company's EBITDA was reported at Rs 865 crore and net profit at Rs 41 crore. A significant highlight includes securing a 10-year biosimilar Pertuzumab PDP partnership in Brazil valued at about USD 400 million.
Read Full Story
Zydus Lifesciences Posts Rs. 79,096 Million Revenue in Q2 FY27 with Net Profit at Rs. 9,255 Million
Zydus Lifesciences Limited reported strong revenue growth of 29% year-on-year in Q2 FY27 at Rs. 79,096 million, driven by its branded pharma businesses in India, North America, and international markets. However, net profit declined 27% to Rs. 9,255 million, and EBITDA dropped 6% to Rs. 18,945 million, reflecting cost and margin pressures.
Read Full Story
